Author

Catia Fonseca

F. Hoffmann-La Roche AG

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Alejandra MartíneziD· 1 shared Amy J. HeidersbachiD· 1 shared Anna SalvioniiD· 1 shared Bastien CabarrouiD· 1 shared Carlos Gomez‐RocaiD· 1 shared Caroline Fournier· 1 shared Catherine Ross· 1 shared Célia Ramade· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alejandra MartínezORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Systemic neoantigen-specific T cells reveal central determinants of PD-(L)1 blockade efficacy

Célia Ramade, Noémie Thébault, Clara‐Maria Scarlata, Daniel Oreper, Françoise Lauzéral-Vizcaïno, Suchit Jhunjhunwala, Bastien Cabarrou, Milena Hornburg, Caroline Fournier, Anna Salvioni, Marie Michelas, Victor Sarradin, Giulia Costanza Leonardi, Virginie Féliu, Myriam Maixent, , Maha Ayyoub

The paper identifies coordinated neoantigen-specific CD8 T cell responses as key predictors of PD-(L)1 therapy efficacy in non-small cell lung cancer patients.

bioRxiv · Mar 12, 2026 · PreprintCancer Biology